Citation, DOI, disclosures and article data
Citation:
Feger J, Knipe H, Machang'a K, Non-dilated left ventricular cardiomyopathy. Reference article, Radiopaedia.org (Accessed on 11 Oct 2024) https://doi.org/10.53347/rID-177267
Disclosures:
At the time the article was last revised Henry Knipe had the following disclosures:
- Integral Diagnostics, Shareholder (ongoing)
- Micro-X Ltd, Shareholder (ongoing)
These were assessed during peer review and were determined to
not be relevant to the changes that were made.
View Henry Knipe's current disclosures
Non-dilated left ventricular cardiomyopathy (NDLVC) refers to a cardiomyopathy phenotype that affects the left ventricle and is characterized by non-ischemic myocardial scarring or fatty replacement with or without regional or global wall-motion abnormalities, or in the setting of global left ventricular wall-motion abnormalities without the presence of myocardial scarring 1.
This includes cardiomyopathic phenotypes that might have been described as dilated cardiomyopathy without dilated left ventricle, arrhythmogenic left ventricular cardiomyopathy (ALVC), left dominant arrhythmogenic right ventricular cardiomyopathy (ARVC) or arrhythmogenic dilated cardiomyopathy (DCM) 1.
History and etymology
The term non-dilated left ventricular cardiomyopathy has been officially introduced by the European Society of Cardiology (ESC) in their '2023 ESC guidelines for the management of cardiomyopathies' 1. The concept, however, had already been proposed earlier by the ESC working group on myocardial and pericardial diseases under the term hypokinetic non-dilated cardiomyopathy in 2016 2 and publications about non-dilated cardiomyopathy were already made earlier e.g. in 2009 and by the Nigerian physicians Basil N Okeahialam and Felix I Anjorin in 1998 3,4.
-
1. Arbelo E, Protonotarios A, Gimeno J et al. 2023 ESC Guidelines for the Management of Cardiomyopathies. Eur Heart J. 2023;44(37):3503-626. doi:10.1093/eurheartj/ehad194 - Pubmed
-
2. Pinto Y, Elliott P, Arbustini E et al. Proposal for a Revised Definition of Dilated Cardiomyopathy, Hypokinetic Non-Dilated Cardiomyopathy, and Its Implications for Clinical Practice: A Position Statement of the ESC Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2016;37(23):1850-8. doi:10.1093/eurheartj/ehv727 - Pubmed
-
3. Draper T, Schick E, Gaasch W. Non-Dilated Cardiomyopathy: Changes in Left Ventricular Size and Function over Time and the Impact of Atrial Fibrillation. J Card Fail. 2009;15(6):S31. doi:10.1016/j.cardfail.2009.06.343
-
4. Okeahialam B & Anjorin F. Non-Dilated Cardiomyopathy in Nigerians Evaluated by Echocardiography. Acta Cardiol. 1998;53(2):97-100. - Pubmed
Promoted articles (advertising)